To aid diagnostics and research during the covid-19 pandemic, Cellink, Boston, has started reselling a quantitative polymerase chain reaction (qPCR) instrument. The instrument monitors the amplification of a targeted DNA molecule in real time, during the PCR process. Quantitative real-time PCR is a proven and stable technology with numerous diagnostic and research applications, including the quantification and genotyping of human viral pathogens such as SARS-CoV-2.
The unit includes dual channels and is an open-source instrument, allowing users to use any kit to run their samples. It is designed as a high-quality, low-throughput qPCR cycler. The instrument is easy to use and runs a sample in 20 to 40 minutes. Cellink wants to help provide scientists with the tools they need to make a difference and therefore offers this instrument at a low-cost point to help advance research related to the covid-19 pandemic.

For more information, visit Cellink.